E-6201

DB11687InvestigationalSmall molecule

E6201 has been investigated for the treatment of Chronic Plaque Psoriasis.

Mechanism: Pharmacologically active on Dual specificity mitogen-activated protein kinase kinase 1 and Mitogen-activated protein kinase kinase kinase 1
Curator reviewed
Formula / weight: C₂₁H₂₇NO₆ · 389.448 g/mol (avg)
Code names: E6201 · ER-806201

Resolves to

Compound

Structure

InChIKeyMWUFVYLAWAXDHQ-HMNLTAHHSA-NSMILESCCNC1=CC2=C(C(O)=C1)C(=O)O[C@@H](C)[C@H](C)\C=C/C(=O)[C@@H](O)[C@@H](O)C\C=C\2

Targets

What you can answer from here — as of June 15, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

6Clinical trialsPhase, status and sponsor resolved per trial

6+ReferencesStructured and connected to the statements they support

Which drugs share a target with E-6201, and which of those have an active Phase 3 trial?

Create a free account or log in to explore the full data card.